AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dofaciti 11mg Tablet

Prescription Icon
Prescription Required

Marketer

Brandoz Pharmaceuticals

Salt Composition

Tofacitinib (11mg)

Overview Dofaciti 11mg Tablet

Rheumacin 11mg tablets effectively manage moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation and slowing the progression of bone and joint deterioration. Rheumacin 11mg may be administered alone or alongside other medications, with or without food, ideally at the same time daily. Dosage is tailored to individual needs and concurrent medications, as directed by your physician. Discontinue use only under medical supervision, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headaches, diarrhea, and nasal inflammation. Less frequent, but potentially serious, adverse events such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Report any concerns to your doctor. Pre-treatment blood work may be required, and the medication should not be initiated during an infection. Prior to treatment, disclose any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Rheumacin 11mg can increase susceptibility to infections or worsen existing ones; avoid contact with contagious individuals (e.g., those with chickenpox, measles, influenza). This medication is contraindicated in individuals under 18 and during pregnancy or breastfeeding, unless deemed medically necessary. Regular monitoring by your physician may be required.

Uses of Dofaciti 11mg Tablet

Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.

Major Benefits of Dofaciti 11mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 11mg Dofaciti tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended for optimal results.

Common Side effects of Dofaciti 11mg Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Dofaciti 11mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dofaciti 11mg Tablets can be consumed with or without food; however, consistent timing is recommended.

How Dofaciti 11mg Tablet works:

Janus kinase inhibition is the mechanism of action for Dofaciti 11mg Tablets. By suppressing Janus kinase enzyme activity, this medication reduces immune system responsiveness and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concomitant use of Dofaciti 11mg Tablet and alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dofaciti 11mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Dofaciti 11mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Dofaciti 11mg Tablets.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the use of Dofaciti 11mg Tablets requires careful monitoring. Dosage modification of Dofaciti 11mg Tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Dofaciti 11mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dofaciti 11mg Tablet :

Should you forget a Dofaciti 11mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dofaciti 11mg Tablet

LabelValue
Type of Compound Pyrrolo[d]pyrimidine compound
Potential for Dependence None.
Type of Medication Medications for Pain Relief
Mechanism of Action Kinase inhibitors targeting Janus kinase

FAQs on Dofaciti 11mg Tablet

Prior to commencing treatment with Dofaciti 11mg Tablet, disclose any existing liver conditions to your physician. This precaution is necessary as Dofaciti 11mg Tablet may elevate liver enzyme levels in certain individuals, necessitating a pre-treatment assessment of liver function. While Dofaciti 11mg Tablet may be administered to patients exhibiting mild to moderate hepatic impairment, its use is contraindicated in those with severe liver dysfunction.
Taking Dofaciti 11mg tablets might raise the likelihood of certain cancers, such as lymphoma and skin cancers, due to its impact on the immune system. Therefore, disclose any history of cancer to your physician.
Eleven-milligram Dofaciti tablets are indicated for individuals experiencing moderate to severe rheumatoid arthritis, a debilitating inflammatory joint disorder. This medication is employed when prior treatments proved ineffective or unsuitable. Alternatively, it may be initiated early in the treatment course should initial drug regimens fail to provide adequate relief. Dofaciti may be administered as a monotherapy or in conjunction with other medications, including methotrexate.
The onset of noticeable improvement with Dofaciti 11mg Tablets typically occurs within two to eight weeks, while achieving the full therapeutic benefit may require three to six months.
Prior to commencing or during treatment with Dofaciti 11mg Tablet, blood work may be necessary. These tests assess for anemia (low red blood cell count), neutropenia or lymphopenia (low white blood cell count), elevated cholesterol (high blood fat), and increased liver enzymes. This monitoring helps determine if Dofaciti 11mg Tablet is causing adverse effects. Furthermore, pre-treatment tuberculosis screening may be recommended by your physician, as Dofaciti 11mg Tablet could potentially exacerbate a pre-existing infection.
Dofaciti 11mg tablets modulate the immune system, potentially diminishing infection resistance and raising the risk of severe infections, such as tuberculosis. These infections may involve serious fungi, bacteria, or viruses disseminated throughout the body. Such infections can be life-threatening and fatal; therefore, hospitalization for their treatment is recommended.
Concurrent use of tocilizumab and Dofaciti 11mg Tablet is contraindicated. Dofaciti 11mg Tablet's immunosuppressive properties necessitate avoidance of concomitant administration with other medications impacting immune function. Combining these drugs elevates infection risk and may precipitate adverse events.
Dofaciti 11mg Tablet
230
MRP 280
17% off